A Phase I/II Clinical Study of Anti-HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 was Included in the Pilot Program for Optimizing the Review and Approval of Clinical Trials for Innovative Drugs SUZHOU, China, Nov. 13, 2024 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK)… CISION PRNewswireNovember 13, 2024
Diligent Launches AI-Powered Due Diligence Reports for Enhanced Supplier and Third-Party Risk Management Diligent AI-powered reports build on history of industry experience to solve major… CISION PRNewswireNovember 13, 2024
Press ReleaseTechMillennium Hotels and Resorts Partners with Aiello to Revolutionize Hospitality with AI Voice Technology Enhancing Guest Experience and Operational Efficiency with Cutting-Edge AI Solutions TAIPEI, Nov.… CISION PRNewswireNovember 13, 2024
Press ReleaseThree Decades of Innovation: Pebsteel's Unstoppable Journey of Greatness in Building HO CHI MINH CITY, Vietnam, Nov. 13, 2024 /PRNewswire/ — Pebsteel, a… CISION PRNewswireNovember 13, 2024
Press ReleaseBLUETTI Unveils Elite 200 Portable Power Station Promising Over 17 Years of Dependable Charging LAS VEGAS, Nov. 13, 2024 /PRNewswire/ — BLUETTI, a leader in portable… CISION PRNewswireNovember 13, 2024
CICG over 75 years: A journey with a translation trailblazer BEIJING, Nov. 13, 2024 /PRNewswire/ — This is a report from China… CISION PRNewswireNovember 13, 2024
Press ReleaseTianma Global Innovation Conference 2024 Successfully Showcased Numerous Breakthroughs XIAMEN, China, Nov. 13, 2024 /PRNewswire/ — On November 6th, Tianma Global Innovation… CISION PRNewswireNovember 13, 2024
Empyrion Digital makes first data centre investment in Thailand Entry into Bangkok marks the fifth investment for the platform after recent… CISION PRNewswireNovember 13, 2024
